Is McKesson Corporation (MCK) overvalued? · P/E 20, rev $403.43B
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
This page asks whether McKesson Corporation (MCK) looks expensive on cached numbers — not a short thesis.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MCK 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MCK stock page for the full model, not this heading.
Not investment advice.